[topsearch__bar__shortcode]

April 2022

Crypto

The week has been just fine for the crypto market. Following are the highlights:

Bitcoin (BTC) has shown a reasonable drop from $41k and down to $37k. The price has dropped down and as a result, has taken the whole market with it. At the time of writing, BTC is being traded at the price of almost $39k. Ethereum (ETH) has been facing difficulty and is staying at just […]

The week has been just fine for the crypto market. Following are the highlights: Read More »

CTK stock

CooTek (Cayman) Inc. (CTK) Collapse After Hours on ADS Ratio Change Plan

CooTek (Cayman) Inc. (CTK) announced on April 28, that it plans to implement an ADS ratio change with a similar effect as a 1-for-13 reverse ADS split. Following the news, the stock collapsed in the after-hours as it plunged much below its 52-week low of $0.1880. Registering a new low of $0.1652, the stock declined

CooTek (Cayman) Inc. (CTK) Collapse After Hours on ADS Ratio Change Plan Read More »

BIOL stock

Biolase Inc. (BIOL) Rebounds After Stock Split News has it Plunge to New Lows

The dental lasers developer, Biolase Inc. (BIOL) witnessed a wild day as investors rushed toward the stock like crazy on April 28, 2022. Intraday trading, the stock saw an unreal volume of 17,823% of its average after the company announced a reverse stock split in connection with its Nasdaq non-compliance. Thus, the stock declined by

Biolase Inc. (BIOL) Rebounds After Stock Split News has it Plunge to New Lows Read More »

ZYME stock

Zymeworks Inc. (ZYME) Soars After hours on $773M Bid from All Blue Capital

On April 28, All Blue Capital which is an investment firm approached Zymeworks Inc. (ZYME) with a $773 million acquisition offer. After initial news was covered by Reuters, the cancer therapy antibodies developer also confirmed the offer later in a press release. Consequently, investors went bullish on ZYME stock, making it surge by 31.85% in

Zymeworks Inc. (ZYME) Soars After hours on $773M Bid from All Blue Capital Read More »

HOOD stock

Robinhood Markets Inc. (HOOD) Reach New Lows After Earnings Disappoint

On April 28, Robinhood Markets Inc. (HOOD) posted earnings for the first quarter of 2022. Shrinking revenue and fewer active users had investors worried for the company. Consequently, the stock fell to new lows in the after-hours following a steep decline of 11.40%. At a volume of 4.53 million shares, HOOD was trading at a

Robinhood Markets Inc. (HOOD) Reach New Lows After Earnings Disappoint Read More »

Sio Gene Therapies Inc. (SIOX) Plunges to New Lows on Terminating License Agreement for its Lead Gene Therapy Programs

Shares of Sio Gene Therapies Inc. (SIOX) are plunging down in the premarket today, on April 28, 2022. So far, SIOX stock has declined by 34.54% registering a new low of $0.3947 in the premarket against its previous 52-week low of $0.5401. This downward move comes after a slight gain of 2.20% in yesterday’s trading

Sio Gene Therapies Inc. (SIOX) Plunges to New Lows on Terminating License Agreement for its Lead Gene Therapy Programs Read More »